Tabernilla, AndrésRego-Pérez, I.Grandal, MartaPernas, BertaPértega-Díaz, SoniaDelgado, ManuelMariño, AnaÁlvarez, HortensiaMena, ÁlvaroRodríguez-Osorio, IriaPedreira Andrade, José DomingoBlanco García, Francisco JPoveda, Eva2026-06-262026-06-262016-10-01Tabernilla A, Rego-Pérez I, Grandal M, Pernas B, Pértega S, Delgado M, Mariño A, Álvarez H, Mena A, Rodríguez-Osorio I, Pedreira JD, Blanco FJ, Poveda E. European mitochondrial haplogroups impact on liver fibrosis progression among HCV and HIV/HCV-coinfected patients from Northwest Spain. J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):149-53.1077-9450https://hdl.handle.net/2183/48661Brief report[Abstract] The impact of mitochondrial DNA haplogroups on the outcome of liver fibrosis was evaluated in 362 hepatitis C virus infection (HCV)-monoinfected and HIV/HCV-coinfected patients (147 and 215, respectively) in clinical follow-up at 2 reference hospitals in the Northwest of Spain. The mitochondrial DNA haplogroup H was the most prevalent (50.3%) in this population. The cluster Others and V were recognized as risk factors for the development of liver fibrosis while haplogroup H and HCV genotype 4 confer a lower risk. This information might be useful for prioritization of HCV treatment, especially for F0-F1 patients for whom there is no urgency for treatment.engThis is a non-final version of an article published in final form in Journal of Acquired Immune Deficiency Syndromes.HIV/HCV coinfectionHCV monoinfectionMitochondrial DNA halogroupsLiver fibrosisjournal articleopen access10.1097/QAI.0000000000001097